Physician profile
Edward H Kaplan
NPI 1639181084
$58,643.90
in general payments reported to CMS, 2019-2025
93 companies · $12K in 2025
The $12K reported for 2025 was more than what 89% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,245 · 2020: $3,382 · 2021: $15K · 2022: $4,793 · 2023: $11K · 2024: $5,092 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $12K · Travel and Lodging: $1,324 · Education: $374 · Long Term Medical Supply Or Device Loan: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,900.00 |
| Food and Beverage | $12,435.30 |
| Travel and Lodging | $1,323.59 |
| Education | $374.12 |
| Long Term Medical Supply Or Device Loan | $249.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $13,341.05 | 2019-2025 | Darzalex, Carvykti, Talvey |
| Astrazeneca Pharmaceuticals LP | $9,442.42 | 2019-2025 | Calquence, Enhertu, Imfinzi |
| Eisai INC. | $5,953.31 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $3,356.77 | 2019-2025 | Kisqali, Piqray |
| Athenex Pharmaceutical Division, LLC | $2,150.00 | 2020-2021 | |
| Novocure INC. | $2,110.05 | 2020-2025 | Optune Lua (Novottf-200t) |
| Pharmacyclics LLC, An Abbvie Company | $2,022.63 | 2019-2023 | Imbruvica, Epkinly |
| Daiichi Sankyo INC. | $1,564.09 | 2019-2025 | Enhertu, Vanflyta, Injectafer |
| Pfizer INC. | $1,257.70 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,252.76 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $1,009.59 | 2019-2025 | Opdualag, Opdivo, Eliquis |
| Incyte Corporation | $932.86 | 2019-2025 | Monjuvi, Jakafi |
| Lilly USA, LLC | $895.33 | 2019-2025 | Verzenio, Jaypirca |
| Amgen INC. | $890.78 | 2019-2024 | Vectibix, Prolia, Nplate |
| Celgene Corporation | $817.39 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $816.40 | 2020-2025 | Fruzaqla, Iclusig, Alunbrig |
| Janssen Scientific Affairs, LLC | $757.50 | 2022 | |
| Genzyme Corporation | $725.26 | 2019-2024 | |
| Genentech USA, INC. | $715.46 | 2019-2025 | Polivy, Columvi, Lunsumio |
| Seagen INC. | $645.97 | 2019-2023 | Adcetris, Tukysa |
| Dendreon Pharmaceuticals LLC | $545.13 | 2019-2025 | Provenge |
| Emd Serono, INC. | $486.83 | 2019-2025 | Tepmetko, Bavencio |
| Abbvie INC. | $479.92 | 2020-2025 | |
| Astellas Pharma US INC | $380.05 | 2019-2024 | Padcev, Xospata, Xtandi |
| Regeneron Healthcare Solutions, INC. | $346.27 | 2019-2024 | Libtayo |
| Beigene USA, INC. | $330.23 | 2020-2025 | Brukinsa |
| Tersera Therapeutics LLC | $302.60 | 2022-2025 | Quzyttir, Zoladex |
| Jazz Pharmaceuticals INC. | $275.38 | 2020-2025 | |
| Adaptive Biotechnologies Corporation | $266.59 | 2021-2025 | Clonoseq |
| Menarini Silicon Biosystems, INC. | $239.94 | 2022-2025 | Cellsearch |
| Gilead Sciences, INC. | $239.93 | 2019-2025 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $232.15 | 2019-2025 | |
| Servier Pharmaceuticals LLC | $218.92 | 2022-2025 | |
| Glaxosmithkline, LLC. | $202.18 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Exelixis INC. | $198.12 | 2019-2025 | Cabometyx |
| Agios Pharmaceuticals, INC. | $168.66 | 2022-2025 | Pyrukynd |
| Pharmacosmos Therapeutics INC. | $167.42 | 2022-2024 | Cosela, Monoferric |
| Blue Earth Diagnostics | $158.10 | 2021-2024 | |
| Array Biopharma INC | $146.56 | 2022-2025 | Lorbrena, Mektovi, Xalkori |
| Blueprint Medicines Corporation | $139.73 | 2022-2024 | Ayvakit |
| Morphosys, US INC. | $128.77 | 2021-2023 | Monjuvi |
| Sobi, INC | $123.42 | 2023-2025 | |
| Karyopharm Therapeutics INC. | $113.52 | 2021-2025 | Xpovio |
| Alnylam Pharmaceuticals INC. | $108.62 | 2020-2025 | Givlaari |
| Springworks Therapeutics, INC. | $103.00 | 2024-2025 | Ogsiveo |
| Deciphera Pharmaceuticals INC. | $95.16 | 2022-2024 | Qinlock |
| Alexion Pharmaceuticals, INC. | $89.90 | 2019-2024 | Ultomiris |
| Mirati Therapeutics, INC. | $82.55 | 2023-2024 | Krazati |
| Kite Pharma, INC. | $82.45 | 2021-2023 | |
| Puma Biotechnology, INC. | $81.21 | 2021-2022 | |
| Spectrum Pharmaceuticals INC. | $76.34 | 2023-2025 | Rolvedon |
| Aveo Pharmaceuticals, INC. | $73.83 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $65.19 | 2023-2024 | Orgovyx |
| Foundation Medicine, INC. | $62.67 | 2021-2023 | |
| Rigel Pharmaceuticals, INC. | $61.88 | 2020-2023 | Rezlidhia, Tavalisse |
| Pharmaessentia USA Corporation | $53.23 | 2023-2024 | Besremi |
| G1 Therapeutics, INC. | $50.76 | 2022-2023 | Cosela |
| Adc Therapeutics America, INC. | $50.46 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $49.05 | 2019-2024 | Xarelto |
| Legend Biotech USA INC. | $48.28 | 2025 | Carvykti |
| Cti Biopharma Corp. | $47.60 | 2023 | Vonjo |
| Amag Pharmaceuticals, INC. | $45.96 | 2020 | |
| Eusa Pharma (US) LLC | $44.63 | 2022 | |
| Ge Healthcare | $44.44 | 2022 | |
| Melinta Therapeutics, LLC | $43.55 | 2024-2025 | Rezzayo, Orbactiv, Kimyrsa |
| Intera Oncology, INC | $42.63 | 2025 | Intera |
| Syndax Pharmaceuticals, INC. | $41.56 | 2025 | |
| Dova Pharmaceuticals | $40.98 | 2021 | |
| Tempus Ai, INC | $39.69 | 2024-2025 | Xt Cdx |
| Taiho Oncology, INC. | $38.53 | 2019-2025 | |
| Fennec Pharmaceuticals, INC. | $32.42 | 2024 | Pedmark |
| Tesaro, INC. | $30.72 | 2019 | |
| Advanced Accelerator Applications | $29.65 | 2019 | |
| Geron Corporation | $28.77 | 2025 | Rytelo |
| Stemline Therapeutics INC. | $28.48 | 2025 | Orserdu |
| Clovis Oncology, INC. | $26.90 | 2019 | |
| Novo Nordisk INC | $26.06 | 2024 | |
| Verastem, INC. | $24.86 | 2020 | |
| Kyowa Kirin, INC. | $23.50 | 2024 | Poteligeo |
| Myriad Genetic Laboratories, INC. | $21.83 | 2022 | |
| Immunogen, INC. | $21.01 | 2023 | Elahere |
| Epizyme, INC. | $19.90 | 2020 | |
| Secura Bio, INC. | $18.62 | 2021 | |
| Acrotech Biopharma INC. | $16.50 | 2023 | Beleodaq |
| Helsinn Therapeutics (U.S.), INC. | $15.99 | 2023 | Akynzeo |
| Invivyd INC | $14.44 | 2025 | Pemgarda |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.32 | 2025 | |
| Immunomedics, INC. | $13.57 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $11.65 | 2019 | |
| Fortovia Therapeutics, INC. | $10.84 | 2020 | |
| Medline Industries LP | $1.98 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Darzalex $8,593Carvykti $8,255Talvey $6,841Tecvayli $3,917Enhertu $2,417Calquence $2,402Provenge $399Kisqali $388Imbruvica $387Keytruda $381Imfinzi $286Opdualag $282Epkinly $257Adcetris $256Lynparza $255Scemblix $253Elrexfio $246Monjuvi $244Venclexta $239Tagrisso $238Polivy $231Cellsearch $227Opdivo $225Xtandi $217Verzenio $214Columvi $214Quzyttir $206Lunsumio $205Brukinsa $194Pomalyst $184Reblozyl $181Erleada $178Piqray $175Jakafi $174Welireg $165Zepzelca $162Talzenna $159Clonoseq $158Fruzaqla $154Ibrance $153Vonjo $148Iclusig $147Lorbrena $146Bosulif $145Tukysa $141Cabometyx $136Inlyta $133Akeega $128Alunbrig $126Lutathera $125Tibsovo $124Ayvakit $122Orgovyx $118Libtayo $113Pluvicto $112Pyrukynd $107Rybrevant $104Ojjaara $104Ogsiveo $103Balversa $98.67Vectibix $95.03Cosela $94.39Promacta $89.44Prolia $87.76Enjaymo $83.80Krazati $82.55Besponsa $77.96Rolvedon $76.34Fabhalta $75.05Fotivda $73.83Padcev $73.30Eliquis $72.91Nplate $72.19Stivarga $71.36Vitrakvi $71.36Vanflyta $70.88Injectafer $70.85Qinlock $68.88Oxbryta $68.49Phesgo $67.95Tasigna $65.22Trodelvy $64.18Ziihera $61.59Cablivi $61.12Nubeqa $61.05Evenity $56.22Besremi $53.23Tepmetko $52.76Elahere $50.69Lenvima $50.34Rezlidhia $49.79Tavalisse $49.79Vpriv $45.77Jaypirca $45.25Comirnaty $45.17Itovebi $44.97Paxlovid $44.76Bavencio $44.51Xalkori $44.25Braftovi $44.25
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.